Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.
about
Sulforaphane as a potential protective phytochemical against neurodegenerative diseasesNew Class of Inhibitors of Amyloid-beta Fibril Formation. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASEInhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compoundsSynaptic vesicle trafficking and Parkinson's diseaseThe role of oxidative stress in Parkinson's diseasep25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathiesDopamine covalently modifies and functionally inactivates parkinThe synucleinsProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesEffects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicityDopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagyBeta-synuclein gene alterations in dementia with Lewy bodies.Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's diseaseRedox Imbalance and Viral Infections in Neurodegenerative DiseasesDynamic structural flexibility of α-synucleinModulation of Protein-Protein Interactions for the Development of Novel TherapeuticsRelevance of chronic stress and the two faces of microglia in Parkinson's diseaseAldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's diseaseThe role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelismFunction and dysfunction of α-synuclein: probing conformational changes and aggregation by single molecule fluorescenceNovel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's diseaseThe contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's diseaseThe phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's diseaseVesicular integrity in Parkinson's diseaseGene-environment interactions: key to unraveling the mystery of Parkinson's diseaseDopamine and paraquat enhance α-synuclein-induced alterations in membrane conductanceThe proteome response to amyloid protein expression in vivoInteractions between Hsp70 and the hydrophobic core of alpha-synuclein inhibit fibril assemblyDopamine-induced α-synuclein oligomers show self- and cross-propagation properties.The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against α-Synuclein Oligomers.From QTL to candidate gene: a genetic approach to alcoholism researchLoss of vesicular dopamine release precedes tauopathy in degenerative dopaminergic neurons in a Drosophila model expressing human tau.The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.Calbindin controls release probability in ventral tegmental area dopamine neurons.Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans.At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to alpha-synuclein and prevents its fibrillationSynthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulationNigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.
P2860
Q21285068-9A405125-11B5-4F05-A672-72C8AA26A825Q22248067-A909EC8F-9691-4F58-96A1-477843D63F7BQ24298231-0A48C474-F441-4FB5-B0FA-ADC952E1AB4EQ24302024-A60D128B-6260-4674-BF0D-2DB27C330BF4Q24307946-CBD64C52-560C-4044-AE34-58D143427592Q24320549-6D6AFB0D-6AFF-4D12-8F3E-A015C12C5A36Q24338423-F33323AD-B562-4FE0-8CA0-58427D6EE048Q24551013-71389D25-075D-474D-9020-10177D8018FCQ24650014-C161A021-6700-40E5-8FEB-08773BE7226DQ24657235-34160F1E-E16D-44AC-B89A-7844116DD89BQ24683066-B82AF9B0-F652-436A-A3A9-00F36B9F246DQ24683089-12E993C0-E45C-4D78-8C94-4F6C1F70E820Q24684579-69179309-3941-4A59-AA6E-F5A425FC1BD6Q24794457-1E9AEB88-2214-4CD7-9BCF-A1F6562D6226Q26750630-3839645F-028A-44A4-B925-EEE4CCA61E14Q26770060-2618C508-3430-4F2D-86C9-23F66EB55575Q26775356-34A57072-9B03-41C1-B43F-7B13D84D152CQ26796241-9BD58660-D070-4DBA-BF48-9710A5B2B898Q26850502-23FC5B47-3E91-4631-8833-B8E4110BD649Q26852148-559A7A59-26AE-477F-9CB3-8E5FE1B3DBE5Q27026292-91D82CD0-15F3-423A-8517-E5916E234AD5Q27301283-79C4CFA7-F732-4AF2-BF3F-9CE92E1D3A84Q28068464-EE4F0404-5B32-4BEA-8583-B5B33555DFB4Q28087330-02D1AEAB-A7B8-4525-8AD6-95BC68C5CAF2Q28385737-58AB1C80-86BB-4D09-8ECC-FE7B7C93373BQ28388674-585776CB-9401-48C0-8D06-9EFF20A4BB7BQ28392011-DF9518C4-B964-4B37-B2E2-58817E1A01EEQ28485287-68A9BB02-16DC-4E51-A866-D2BA6891D2A8Q28910341-A6B9259A-1784-499E-8B81-7628303DCC97Q30364908-8E604FF9-1999-46A6-A739-99E8B5B289D4Q30376382-C4E1D6B8-9795-439C-8195-15A299ABBEC9Q30409923-456CB32E-74EE-4E1B-8033-03195BCE8D0DQ30419801-D23C5428-A75B-4466-9CA3-2A8E9939662AQ30430534-6A104E29-6CBA-4685-B012-B9237FB5C152Q30452597-990C77E0-7D82-418A-A2B2-51F313B9DF1CQ30476174-55540923-EBB0-4C3E-9D0A-8EE210958ECCQ30481562-BD59DE2D-4345-4605-91EE-671E15870600Q30575408-B6861F57-3724-4485-9D25-3DE5762ACF5DQ30581658-6AC9B70D-D0FA-4A68-B7F9-23778C2228D2Q31132651-089162BB-52F8-4FB1-80B9-39214CB5C5B5
P2860
Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Kinetic stabilization of the a ...... pamine-alpha-synuclein adduct.
@ast
Kinetic stabilization of the a ...... pamine-alpha-synuclein adduct.
@en
type
label
Kinetic stabilization of the a ...... pamine-alpha-synuclein adduct.
@ast
Kinetic stabilization of the a ...... pamine-alpha-synuclein adduct.
@en
prefLabel
Kinetic stabilization of the a ...... pamine-alpha-synuclein adduct.
@ast
Kinetic stabilization of the a ...... pamine-alpha-synuclein adduct.
@en
P2093
P356
P1433
P1476
Kinetic stabilization of the a ...... pamine-alpha-synuclein adduct.
@en
P2093
Bieganski RM
Lansbury PT Jr
P304
P356
10.1126/SCIENCE.1063522
P407
P577
2001-11-01T00:00:00Z